Overview

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify a dose of P276-00 that can be safely administered along with Radiation and to examine safety and efficacy of the combination in treatment of advanced head and neck cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Piramal Enterprises Limited
Treatments:
Cyclin-Dependent Kinase Inhibitor Proteins